Enter assignee name

EPO Patents = 4

Forward Citations = 52

Loading Chart...

4 inventors (with patents filed for the assignee):

Gulilat Gebeyehu (16 out of 45 patents)

Joel A Jessee (16 out of 39 patents)

Robert L Bebee (2 out of 2 patents)

4. Taysir M Jaouni (2 out of 2 patents)

18 patents: Sort by Forward Citations

1. 12065665 - Agents for improved delivery of nucleic acids to eukaryotic cells (2024-08-20),

2. 12043639 - Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells (2024-07-23),

3. 12037600 - Transfection complexes and methods of using the same (2024-07-16),

4. 11866723 - Plant virus movement proteins and methods of using same (2024-01-09),

5. 11085056 - Transfection complexes and methods of using the same (2021-08-10),

6. 10968240 - Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells (2021-04-06),

7. 10883118 - Agents for improved delivery of nucleic acids to eukaryotic cells (2021-01-05),

8. 10538784 - Plant virus movement proteins and methods of using the same (2020-01-21),

9. 10155780 - Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells (2018-12-18),

10. 10138497 - Agents for improved delivery of nucleic acids to eukaryotic cells (2018-11-27),

11. 9765359 - Agents for improved delivery of nucleic acids to eukaryotic cells (2017-09-19),

12. 9259475 - Agents for improved delivery of nucleic acids to eukaryotic cells (2016-02-16),

13. 8759499 - Lipids for transfection of Eukaryotic cells (2014-06-24),

14. 8105818 - Ready-to-use electroporation cuvette including frozen electrocompetent cells (2012-01-31),

15. 8034977 - Lipids for transfection of nucleic acids (2011-10-11),

Molecular Transfer, Inc. is a biotechnology company based in Gaithersburg, Maryland, specializing in advanced drug delivery systems. The organization focuses on developing innovative technologies that enhance the efficacy and safety of therapeutic agents. Their research encompasses areas such as nanotechnology and molecular engineering, aiming to improve patient outcomes through targeted delivery mechanisms. With a commitment to scientific excellence, Molecular Transfer is positioned at the forefront of biopharmaceutical advancements.

Profile summary based on public USPTO records.